| 摘要 |
<p>Recurrence-free survival time-extending agents for patients with lung squamous carcinoma at the pathologic histological stage I which contain aminopeptidase inhibitors such as ubenimex as the active ingredient; or survival time-extending agents, in particular, recurrence-free survival time-extending agents for patients with the same disease at the pathologic histological stage IB after lung cancer removal.</p> |
